Serum Proteomic Profiling by SomaScan Aptamer Array Identifies Candidate Predictive and Monitoring Biomarkers of Distant Recurrence in Triple-Negative Breast Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27209070 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Jina Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA 90069, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Biomarkers, Tumor, Proteomics, Neoplasm Recurrence, Local. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cedars-Sinai Cancer, Cedars-Sinai Cancer Phoenix Funding Initiative.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) lacks a blood-based biomarker for predicting or monitoring distant recurrence. We profiled 39 serum samples from 38 women (10 healthy controls; 12 non-recurrent [NR]; eight diagnosis-timepoint samples from patients who later recurred [DR-DIG]; nine recurrence-timepoint samples [DR-REC]) using the SomaScan v5.0 aptamer platform). Public tumor-tissue transcriptomic cohorts were used for supportive and exploratory analyses. No protein reached a false discovery rate (FDR) < 0.05 for NR vs. DR-DIG; granzyme A (GZMA) and endoplasmic reticulum aminopeptidase 1 (ERAP1) showed the strongest nominal signals. For DR-DIG vs. DR-REC, 38 aptamers (37 proteins) reached FDR < 0.05, enriched for RNA-binding and nuclear-envelope proteins; this signature was retained in leave-one-out and storage-adjusted analyses. Higher GZMA mRNA was associated with longer recurrence-free survival in two independent cohorts (hazard ratio [HR] = 0.795, p = 0.018; HR = 0.186, p = 0.0057). Monitor genes showed near-chance concordance with metastatic tissue, and the source of the signature could not be resolved. An exploratory four-gene elastic-net panel reached a concordance index of 0.613 internally but 0.559 externally. GZMA is a candidate serum biomarker of TNBC recurrence risk, and the monitor signature is a preliminary observation. Both require protein-level validation in independent, prospectively collected serum cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, CA 90069, USA.
- Department of Urology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
- Department of Electrical and Computer Engineering, The University of Texas at Austin, Austin, TX 78712, USA.
- California Institute of Technology, Pasadena, CA 91125, USA.
- Department of Breast Surgery, Graduate School of Medicine, Kyoto University, Kyoto 6068507, Japan.
ORCID-Profile: Edwardia Fosah, Thanosan Prathifkumar, Yukiko Fukui, Masahiro Kawashima, Norikazu Masuda, Takeo Fujii, Sungyong You, Hideki Furuya
Förderung
- Cedars-Sinai Cancer
- Cedars-Sinai Cancer Phoenix Funding Initiative
Zitieren
APA
Kim, J., Tanaka, S., Fosah, E., Jinno, C., Kim, H., Prathifkumar, T., Fukui, Y., Kawanishi, K., Kawashima, M., Masuda, N., Levy, J., Fujii, T., You, S., & Furuya, H. (2026). Serum Proteomic Profiling by SomaScan Aptamer Array Identifies Candidate Predictive and Monitoring Biomarkers of Distant Recurrence in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27209070
Vancouver
Kim J, Tanaka S, Fosah E, Jinno C, Kim H, Prathifkumar T, et al. Serum Proteomic Profiling by SomaScan Aptamer Array Identifies Candidate Predictive and Monitoring Biomarkers of Distant Recurrence in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27209070
BibTeX
@article{Kim2026,
author = {Kim, Jina and Tanaka, Sunao and Fosah, Edwardia and Jinno, Cynthia and Kim, Hyoyoung and Prathifkumar, Thanosan and Fukui, Yukiko and Kawanishi, Kana and Kawashima, Masahiro and Masuda, Norikazu and Levy, Joshua and Fujii, Takeo and You, Sungyong and Furuya, Hideki},
title = {Serum Proteomic Profiling by SomaScan Aptamer Array Identifies Candidate Predictive and Monitoring Biomarkers of Distant Recurrence in Triple-Negative Breast Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27209070}
}
EUVIMED